This Expert Column discusses the FTC’s ongoing efforts to address these abuses as well as the latest developments in litigation over improper patent listings that delay access to generic drugs.
Aiseosa Osaghae
Andrew J. Twinamatsiko Katie Keith
Center for Global Health Policy and Politics
Laura Dragnic Tohá Guillermina Pappier Paulina Macías Ortega Rebecca Reingold
Kashish Aneja Lawrence O. Gostin Sam Halabi
Katie Keith Suhasini Ravi
Sarah Wetter Rebecca Reingold Divya Ganesan
Emily Carrazana Ivonne Garza
Giovanna Camargo Messner Neves
Sarah L. Bosha Adi Radhakrishnan Ikponwosa Ero
Paulina Macías Ortega Guillermina Pappier Laura Dragnic Tohá
Regina LaBelle David R. Holtgrave
Andrew J. Twinamatsiko Katie Keith
Zachary L. Baron Katie Keith Andrew J. Twinamatsiko
Andrew J. Twinamatsiko Katie Keith
Center for Global Health Policy and Politics
Laura Dragnic Tohá Guillermina Pappier Paulina Macías Ortega Rebecca Reingold
